DIABETES CARE 润色咨询

DIABETES CARE

出版年份:1978 年文章数:5172 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:5.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2140870, encodeId=5f2e21408e06e, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:23:03 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140871, encodeId=865121408e103, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:24:27 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140869, encodeId=69522140869b6, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:22:48 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137338, encodeId=3ba3213e3388a, content=偏重的研究方向:糖尿病<br>经验分享:收综述文章嘛(小白求指教), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae28688265, createdName=ms3000001390660790, createdTime=Wed May 17 23:49:59 CST 2023, time=2023-05-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2101625, encodeId=6a3821016259e, content=偏重的研究方向:流行病学;糖尿病;临床<br>经验分享:终于被接受了,不容易啊,历时六个月了。 杂志内审外审等流程都比较严谨,要求也挺高。 一般内审1-2周(编辑审查格式是否规范及是否适合外审),外审一般4—6周。碰上暑假容易被搁置而延长投稿时间。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sun Nov 20 13:58:55 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099507, encodeId=7b17209950ef1, content=审稿速度:1.0<br>经验分享:审稿速度非常快,希望大家都能中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6f92388264, createdName=snowballball, createdTime=Wed Nov 09 22:46:28 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236992, encodeId=676712369927c, content=under review两个月,还是没任何消息会状态变动。投的是letter。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sat Aug 06 21:46:56 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098357, encodeId=4a3c209835e99, content=这个杂志是不是不收综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc586144600, createdName=ms8000001610966126, createdTime=Thu Nov 03 21:52:20 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248006, encodeId=7b48124800667, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:8.15号投稿 9.2大修 给了一个月时间 求保佑!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/5080ac1b33f84e528805dfb385924068/7784cf4d9a3c4faa9435bfad48d5a3b0.jpg, createdBy=effc5704702, createdName=ms8000000410198978, createdTime=Fri Sep 09 00:11:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182580, encodeId=287711825803d, content=偏重的研究方向:糖尿病肾病;流行病学;糖尿病<br>经验分享:文章接收了!杂志效率还是很快!第一次修回3周,第二次修回3周,然后接收!ps:小修也会再送回审稿人那哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bdb2437527, createdName=123c9efcm11暂无昵称, createdTime=Sun Jan 09 17:56:32 CST 2022, time=2022-01-09, status=1, ipAttribution=)]
    2023-06-05 ms1000000535106272 来自江苏省

    偏重的研究方向:流行病学;糖尿病
    经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2140870, encodeId=5f2e21408e06e, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:23:03 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140871, encodeId=865121408e103, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:24:27 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140869, encodeId=69522140869b6, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:22:48 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137338, encodeId=3ba3213e3388a, content=偏重的研究方向:糖尿病<br>经验分享:收综述文章嘛(小白求指教), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae28688265, createdName=ms3000001390660790, createdTime=Wed May 17 23:49:59 CST 2023, time=2023-05-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2101625, encodeId=6a3821016259e, content=偏重的研究方向:流行病学;糖尿病;临床<br>经验分享:终于被接受了,不容易啊,历时六个月了。 杂志内审外审等流程都比较严谨,要求也挺高。 一般内审1-2周(编辑审查格式是否规范及是否适合外审),外审一般4—6周。碰上暑假容易被搁置而延长投稿时间。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sun Nov 20 13:58:55 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099507, encodeId=7b17209950ef1, content=审稿速度:1.0<br>经验分享:审稿速度非常快,希望大家都能中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6f92388264, createdName=snowballball, createdTime=Wed Nov 09 22:46:28 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236992, encodeId=676712369927c, content=under review两个月,还是没任何消息会状态变动。投的是letter。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sat Aug 06 21:46:56 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098357, encodeId=4a3c209835e99, content=这个杂志是不是不收综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc586144600, createdName=ms8000001610966126, createdTime=Thu Nov 03 21:52:20 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248006, encodeId=7b48124800667, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:8.15号投稿 9.2大修 给了一个月时间 求保佑!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/5080ac1b33f84e528805dfb385924068/7784cf4d9a3c4faa9435bfad48d5a3b0.jpg, createdBy=effc5704702, createdName=ms8000000410198978, createdTime=Fri Sep 09 00:11:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182580, encodeId=287711825803d, content=偏重的研究方向:糖尿病肾病;流行病学;糖尿病<br>经验分享:文章接收了!杂志效率还是很快!第一次修回3周,第二次修回3周,然后接收!ps:小修也会再送回审稿人那哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bdb2437527, createdName=123c9efcm11暂无昵称, createdTime=Sun Jan 09 17:56:32 CST 2022, time=2022-01-09, status=1, ipAttribution=)]
    2023-06-05 ms1000000535106272 来自江苏省

    偏重的研究方向:流行病学;糖尿病
    经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2140870, encodeId=5f2e21408e06e, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:23:03 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140871, encodeId=865121408e103, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:24:27 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140869, encodeId=69522140869b6, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:22:48 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137338, encodeId=3ba3213e3388a, content=偏重的研究方向:糖尿病<br>经验分享:收综述文章嘛(小白求指教), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae28688265, createdName=ms3000001390660790, createdTime=Wed May 17 23:49:59 CST 2023, time=2023-05-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2101625, encodeId=6a3821016259e, content=偏重的研究方向:流行病学;糖尿病;临床<br>经验分享:终于被接受了,不容易啊,历时六个月了。 杂志内审外审等流程都比较严谨,要求也挺高。 一般内审1-2周(编辑审查格式是否规范及是否适合外审),外审一般4—6周。碰上暑假容易被搁置而延长投稿时间。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sun Nov 20 13:58:55 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099507, encodeId=7b17209950ef1, content=审稿速度:1.0<br>经验分享:审稿速度非常快,希望大家都能中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6f92388264, createdName=snowballball, createdTime=Wed Nov 09 22:46:28 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236992, encodeId=676712369927c, content=under review两个月,还是没任何消息会状态变动。投的是letter。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sat Aug 06 21:46:56 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098357, encodeId=4a3c209835e99, content=这个杂志是不是不收综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc586144600, createdName=ms8000001610966126, createdTime=Thu Nov 03 21:52:20 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248006, encodeId=7b48124800667, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:8.15号投稿 9.2大修 给了一个月时间 求保佑!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/5080ac1b33f84e528805dfb385924068/7784cf4d9a3c4faa9435bfad48d5a3b0.jpg, createdBy=effc5704702, createdName=ms8000000410198978, createdTime=Fri Sep 09 00:11:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182580, encodeId=287711825803d, content=偏重的研究方向:糖尿病肾病;流行病学;糖尿病<br>经验分享:文章接收了!杂志效率还是很快!第一次修回3周,第二次修回3周,然后接收!ps:小修也会再送回审稿人那哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bdb2437527, createdName=123c9efcm11暂无昵称, createdTime=Sun Jan 09 17:56:32 CST 2022, time=2022-01-09, status=1, ipAttribution=)]
    2023-06-05 ms1000000535106272 来自江苏省

    偏重的研究方向:流行病学;糖尿病
    经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2140870, encodeId=5f2e21408e06e, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:23:03 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140871, encodeId=865121408e103, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:24:27 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140869, encodeId=69522140869b6, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:22:48 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137338, encodeId=3ba3213e3388a, content=偏重的研究方向:糖尿病<br>经验分享:收综述文章嘛(小白求指教), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae28688265, createdName=ms3000001390660790, createdTime=Wed May 17 23:49:59 CST 2023, time=2023-05-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2101625, encodeId=6a3821016259e, content=偏重的研究方向:流行病学;糖尿病;临床<br>经验分享:终于被接受了,不容易啊,历时六个月了。 杂志内审外审等流程都比较严谨,要求也挺高。 一般内审1-2周(编辑审查格式是否规范及是否适合外审),外审一般4—6周。碰上暑假容易被搁置而延长投稿时间。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sun Nov 20 13:58:55 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099507, encodeId=7b17209950ef1, content=审稿速度:1.0<br>经验分享:审稿速度非常快,希望大家都能中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6f92388264, createdName=snowballball, createdTime=Wed Nov 09 22:46:28 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236992, encodeId=676712369927c, content=under review两个月,还是没任何消息会状态变动。投的是letter。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sat Aug 06 21:46:56 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098357, encodeId=4a3c209835e99, content=这个杂志是不是不收综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc586144600, createdName=ms8000001610966126, createdTime=Thu Nov 03 21:52:20 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248006, encodeId=7b48124800667, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:8.15号投稿 9.2大修 给了一个月时间 求保佑!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/5080ac1b33f84e528805dfb385924068/7784cf4d9a3c4faa9435bfad48d5a3b0.jpg, createdBy=effc5704702, createdName=ms8000000410198978, createdTime=Fri Sep 09 00:11:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182580, encodeId=287711825803d, content=偏重的研究方向:糖尿病肾病;流行病学;糖尿病<br>经验分享:文章接收了!杂志效率还是很快!第一次修回3周,第二次修回3周,然后接收!ps:小修也会再送回审稿人那哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bdb2437527, createdName=123c9efcm11暂无昵称, createdTime=Sun Jan 09 17:56:32 CST 2022, time=2022-01-09, status=1, ipAttribution=)]
    2023-05-17 ms3000001390660790 来自辽宁省

    偏重的研究方向:糖尿病
    经验分享:收综述文章嘛(小白求指教)

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2140870, encodeId=5f2e21408e06e, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:23:03 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140871, encodeId=865121408e103, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:24:27 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140869, encodeId=69522140869b6, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:22:48 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137338, encodeId=3ba3213e3388a, content=偏重的研究方向:糖尿病<br>经验分享:收综述文章嘛(小白求指教), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae28688265, createdName=ms3000001390660790, createdTime=Wed May 17 23:49:59 CST 2023, time=2023-05-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2101625, encodeId=6a3821016259e, content=偏重的研究方向:流行病学;糖尿病;临床<br>经验分享:终于被接受了,不容易啊,历时六个月了。 杂志内审外审等流程都比较严谨,要求也挺高。 一般内审1-2周(编辑审查格式是否规范及是否适合外审),外审一般4—6周。碰上暑假容易被搁置而延长投稿时间。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sun Nov 20 13:58:55 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099507, encodeId=7b17209950ef1, content=审稿速度:1.0<br>经验分享:审稿速度非常快,希望大家都能中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6f92388264, createdName=snowballball, createdTime=Wed Nov 09 22:46:28 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236992, encodeId=676712369927c, content=under review两个月,还是没任何消息会状态变动。投的是letter。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sat Aug 06 21:46:56 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098357, encodeId=4a3c209835e99, content=这个杂志是不是不收综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc586144600, createdName=ms8000001610966126, createdTime=Thu Nov 03 21:52:20 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248006, encodeId=7b48124800667, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:8.15号投稿 9.2大修 给了一个月时间 求保佑!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/5080ac1b33f84e528805dfb385924068/7784cf4d9a3c4faa9435bfad48d5a3b0.jpg, createdBy=effc5704702, createdName=ms8000000410198978, createdTime=Fri Sep 09 00:11:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182580, encodeId=287711825803d, content=偏重的研究方向:糖尿病肾病;流行病学;糖尿病<br>经验分享:文章接收了!杂志效率还是很快!第一次修回3周,第二次修回3周,然后接收!ps:小修也会再送回审稿人那哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bdb2437527, createdName=123c9efcm11暂无昵称, createdTime=Sun Jan 09 17:56:32 CST 2022, time=2022-01-09, status=1, ipAttribution=)]
    2022-11-20 ms9000000252581768

    偏重的研究方向:流行病学;糖尿病;临床
    经验分享:终于被接受了,不容易啊,历时六个月了。 杂志内审外审等流程都比较严谨,要求也挺高。 一般内审1-2周(编辑审查格式是否规范及是否适合外审),外审一般4—6周。碰上暑假容易被搁置而延长投稿时间。

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2140870, encodeId=5f2e21408e06e, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:23:03 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140871, encodeId=865121408e103, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:24:27 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140869, encodeId=69522140869b6, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:22:48 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137338, encodeId=3ba3213e3388a, content=偏重的研究方向:糖尿病<br>经验分享:收综述文章嘛(小白求指教), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae28688265, createdName=ms3000001390660790, createdTime=Wed May 17 23:49:59 CST 2023, time=2023-05-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2101625, encodeId=6a3821016259e, content=偏重的研究方向:流行病学;糖尿病;临床<br>经验分享:终于被接受了,不容易啊,历时六个月了。 杂志内审外审等流程都比较严谨,要求也挺高。 一般内审1-2周(编辑审查格式是否规范及是否适合外审),外审一般4—6周。碰上暑假容易被搁置而延长投稿时间。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sun Nov 20 13:58:55 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099507, encodeId=7b17209950ef1, content=审稿速度:1.0<br>经验分享:审稿速度非常快,希望大家都能中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6f92388264, createdName=snowballball, createdTime=Wed Nov 09 22:46:28 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236992, encodeId=676712369927c, content=under review两个月,还是没任何消息会状态变动。投的是letter。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sat Aug 06 21:46:56 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098357, encodeId=4a3c209835e99, content=这个杂志是不是不收综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc586144600, createdName=ms8000001610966126, createdTime=Thu Nov 03 21:52:20 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248006, encodeId=7b48124800667, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:8.15号投稿 9.2大修 给了一个月时间 求保佑!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/5080ac1b33f84e528805dfb385924068/7784cf4d9a3c4faa9435bfad48d5a3b0.jpg, createdBy=effc5704702, createdName=ms8000000410198978, createdTime=Fri Sep 09 00:11:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182580, encodeId=287711825803d, content=偏重的研究方向:糖尿病肾病;流行病学;糖尿病<br>经验分享:文章接收了!杂志效率还是很快!第一次修回3周,第二次修回3周,然后接收!ps:小修也会再送回审稿人那哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bdb2437527, createdName=123c9efcm11暂无昵称, createdTime=Sun Jan 09 17:56:32 CST 2022, time=2022-01-09, status=1, ipAttribution=)]
    2022-11-09 snowballball

    审稿速度:1.0
    经验分享:审稿速度非常快,希望大家都能中!

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2140870, encodeId=5f2e21408e06e, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:23:03 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140871, encodeId=865121408e103, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:24:27 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140869, encodeId=69522140869b6, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:22:48 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137338, encodeId=3ba3213e3388a, content=偏重的研究方向:糖尿病<br>经验分享:收综述文章嘛(小白求指教), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae28688265, createdName=ms3000001390660790, createdTime=Wed May 17 23:49:59 CST 2023, time=2023-05-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2101625, encodeId=6a3821016259e, content=偏重的研究方向:流行病学;糖尿病;临床<br>经验分享:终于被接受了,不容易啊,历时六个月了。 杂志内审外审等流程都比较严谨,要求也挺高。 一般内审1-2周(编辑审查格式是否规范及是否适合外审),外审一般4—6周。碰上暑假容易被搁置而延长投稿时间。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sun Nov 20 13:58:55 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099507, encodeId=7b17209950ef1, content=审稿速度:1.0<br>经验分享:审稿速度非常快,希望大家都能中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6f92388264, createdName=snowballball, createdTime=Wed Nov 09 22:46:28 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236992, encodeId=676712369927c, content=under review两个月,还是没任何消息会状态变动。投的是letter。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sat Aug 06 21:46:56 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098357, encodeId=4a3c209835e99, content=这个杂志是不是不收综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc586144600, createdName=ms8000001610966126, createdTime=Thu Nov 03 21:52:20 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248006, encodeId=7b48124800667, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:8.15号投稿 9.2大修 给了一个月时间 求保佑!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/5080ac1b33f84e528805dfb385924068/7784cf4d9a3c4faa9435bfad48d5a3b0.jpg, createdBy=effc5704702, createdName=ms8000000410198978, createdTime=Fri Sep 09 00:11:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182580, encodeId=287711825803d, content=偏重的研究方向:糖尿病肾病;流行病学;糖尿病<br>经验分享:文章接收了!杂志效率还是很快!第一次修回3周,第二次修回3周,然后接收!ps:小修也会再送回审稿人那哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bdb2437527, createdName=123c9efcm11暂无昵称, createdTime=Sun Jan 09 17:56:32 CST 2022, time=2022-01-09, status=1, ipAttribution=)]
    2022-08-06 ms9000000252581768

    under review两个月,还是没任何消息会状态变动。投的是letter。

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2140870, encodeId=5f2e21408e06e, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:23:03 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140871, encodeId=865121408e103, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:24:27 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140869, encodeId=69522140869b6, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:22:48 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137338, encodeId=3ba3213e3388a, content=偏重的研究方向:糖尿病<br>经验分享:收综述文章嘛(小白求指教), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae28688265, createdName=ms3000001390660790, createdTime=Wed May 17 23:49:59 CST 2023, time=2023-05-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2101625, encodeId=6a3821016259e, content=偏重的研究方向:流行病学;糖尿病;临床<br>经验分享:终于被接受了,不容易啊,历时六个月了。 杂志内审外审等流程都比较严谨,要求也挺高。 一般内审1-2周(编辑审查格式是否规范及是否适合外审),外审一般4—6周。碰上暑假容易被搁置而延长投稿时间。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sun Nov 20 13:58:55 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099507, encodeId=7b17209950ef1, content=审稿速度:1.0<br>经验分享:审稿速度非常快,希望大家都能中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6f92388264, createdName=snowballball, createdTime=Wed Nov 09 22:46:28 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236992, encodeId=676712369927c, content=under review两个月,还是没任何消息会状态变动。投的是letter。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sat Aug 06 21:46:56 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098357, encodeId=4a3c209835e99, content=这个杂志是不是不收综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc586144600, createdName=ms8000001610966126, createdTime=Thu Nov 03 21:52:20 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248006, encodeId=7b48124800667, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:8.15号投稿 9.2大修 给了一个月时间 求保佑!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/5080ac1b33f84e528805dfb385924068/7784cf4d9a3c4faa9435bfad48d5a3b0.jpg, createdBy=effc5704702, createdName=ms8000000410198978, createdTime=Fri Sep 09 00:11:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182580, encodeId=287711825803d, content=偏重的研究方向:糖尿病肾病;流行病学;糖尿病<br>经验分享:文章接收了!杂志效率还是很快!第一次修回3周,第二次修回3周,然后接收!ps:小修也会再送回审稿人那哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bdb2437527, createdName=123c9efcm11暂无昵称, createdTime=Sun Jan 09 17:56:32 CST 2022, time=2022-01-09, status=1, ipAttribution=)]
    2022-11-03 ms8000001610966126

    这个杂志是不是不收综述

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2140870, encodeId=5f2e21408e06e, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:23:03 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140871, encodeId=865121408e103, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:24:27 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140869, encodeId=69522140869b6, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:22:48 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137338, encodeId=3ba3213e3388a, content=偏重的研究方向:糖尿病<br>经验分享:收综述文章嘛(小白求指教), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae28688265, createdName=ms3000001390660790, createdTime=Wed May 17 23:49:59 CST 2023, time=2023-05-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2101625, encodeId=6a3821016259e, content=偏重的研究方向:流行病学;糖尿病;临床<br>经验分享:终于被接受了,不容易啊,历时六个月了。 杂志内审外审等流程都比较严谨,要求也挺高。 一般内审1-2周(编辑审查格式是否规范及是否适合外审),外审一般4—6周。碰上暑假容易被搁置而延长投稿时间。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sun Nov 20 13:58:55 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099507, encodeId=7b17209950ef1, content=审稿速度:1.0<br>经验分享:审稿速度非常快,希望大家都能中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6f92388264, createdName=snowballball, createdTime=Wed Nov 09 22:46:28 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236992, encodeId=676712369927c, content=under review两个月,还是没任何消息会状态变动。投的是letter。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sat Aug 06 21:46:56 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098357, encodeId=4a3c209835e99, content=这个杂志是不是不收综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc586144600, createdName=ms8000001610966126, createdTime=Thu Nov 03 21:52:20 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248006, encodeId=7b48124800667, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:8.15号投稿 9.2大修 给了一个月时间 求保佑!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/5080ac1b33f84e528805dfb385924068/7784cf4d9a3c4faa9435bfad48d5a3b0.jpg, createdBy=effc5704702, createdName=ms8000000410198978, createdTime=Fri Sep 09 00:11:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182580, encodeId=287711825803d, content=偏重的研究方向:糖尿病肾病;流行病学;糖尿病<br>经验分享:文章接收了!杂志效率还是很快!第一次修回3周,第二次修回3周,然后接收!ps:小修也会再送回审稿人那哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bdb2437527, createdName=123c9efcm11暂无昵称, createdTime=Sun Jan 09 17:56:32 CST 2022, time=2022-01-09, status=1, ipAttribution=)]
    2022-09-09 ms8000000410198978

    偏重的研究方向:流行病学;糖尿病
    经验分享:8.15号投稿 9.2大修 给了一个月时间 求保佑!

    12

    展开12条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2140870, encodeId=5f2e21408e06e, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:23:03 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140871, encodeId=865121408e103, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:24:27 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2140869, encodeId=69522140869b6, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:请教一下大家,投稿要上传的“Manuscript Submission Form”文件中“Manuscript #:”是要填ID号吗?还是填其他什么内容,但是没提交之前文章ID我看是暂未生成的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70938118113, createdName=ms1000000535106272, createdTime=Mon Jun 05 10:22:48 CST 2023, time=2023-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137338, encodeId=3ba3213e3388a, content=偏重的研究方向:糖尿病<br>经验分享:收综述文章嘛(小白求指教), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae28688265, createdName=ms3000001390660790, createdTime=Wed May 17 23:49:59 CST 2023, time=2023-05-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2101625, encodeId=6a3821016259e, content=偏重的研究方向:流行病学;糖尿病;临床<br>经验分享:终于被接受了,不容易啊,历时六个月了。 杂志内审外审等流程都比较严谨,要求也挺高。 一般内审1-2周(编辑审查格式是否规范及是否适合外审),外审一般4—6周。碰上暑假容易被搁置而延长投稿时间。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sun Nov 20 13:58:55 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099507, encodeId=7b17209950ef1, content=审稿速度:1.0<br>经验分享:审稿速度非常快,希望大家都能中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6f92388264, createdName=snowballball, createdTime=Wed Nov 09 22:46:28 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236992, encodeId=676712369927c, content=under review两个月,还是没任何消息会状态变动。投的是letter。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff65526905, createdName=ms9000000252581768, createdTime=Sat Aug 06 21:46:56 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098357, encodeId=4a3c209835e99, content=这个杂志是不是不收综述, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc586144600, createdName=ms8000001610966126, createdTime=Thu Nov 03 21:52:20 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248006, encodeId=7b48124800667, content=偏重的研究方向:流行病学;糖尿病<br>经验分享:8.15号投稿 9.2大修 给了一个月时间 求保佑!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/5080ac1b33f84e528805dfb385924068/7784cf4d9a3c4faa9435bfad48d5a3b0.jpg, createdBy=effc5704702, createdName=ms8000000410198978, createdTime=Fri Sep 09 00:11:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182580, encodeId=287711825803d, content=偏重的研究方向:糖尿病肾病;流行病学;糖尿病<br>经验分享:文章接收了!杂志效率还是很快!第一次修回3周,第二次修回3周,然后接收!ps:小修也会再送回审稿人那哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bdb2437527, createdName=123c9efcm11暂无昵称, createdTime=Sun Jan 09 17:56:32 CST 2022, time=2022-01-09, status=1, ipAttribution=)]
    2022-01-09 123c9efcm11暂无昵称

    偏重的研究方向:糖尿病肾病;流行病学;糖尿病
    经验分享:文章接收了!杂志效率还是很快!第一次修回3周,第二次修回3周,然后接收!ps:小修也会再送回审稿人那哦

    4

    展开4条回复
共82条页码: 1/9页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分